Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verteporfin Photodynamic Therapy in Primary Soft Tissue Sarcoma of the Limbs
2010-019714-24Phase 2Unknown
- Sponsor
- Research & Development Department
- Start
- Jul 2010
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of verteporfin in soft tissue sarcoma (STS), sponsored by Research & Development Department. Primary endpoint: Maximum diameter of necrosis for given light energy. Status: unknown.
02
Drugs
verteporfin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2010-019714-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019714-24.